SEC Form 4 · accession 0001213900-17-000008
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sandesh Seth
Officer — Executive Chairman · Director
Period of report
Dec 30, 2016
Accepted (ET)
Jan 3, 2017 · 8:00 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 30, 2016 | P | 5,000 | $0.88 | A | 35,000 | D |
Table II — derivative securities
No Table II lines on this filing.